SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-24-001539
Filing Date
2024-02-09
Accepted
2024-02-09 16:20:33
Documents
18
Period of Report
2024-02-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K edsa_8k.htm   iXBRL 8-K 25229
2 PRESS RELEASE edsa_ex991.htm EX-99.1 84864
8 edsa_ex991img2.jpg GRAPHIC 3303
  Complete submission text file 0001654954-24-001539.txt   243077

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA edsa-20240209.xsd EX-101.SCH 5720
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE edsa-20240209_lab.xml EX-101.LAB 14059
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE edsa-20240209_cal.xml EX-101.CAL 898
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE edsa-20240209_pre.xml EX-101.PRE 8880
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE edsa-20240209_def.xml EX-101.DEF 2099
20 EXTRACTED XBRL INSTANCE DOCUMENT edsa_8k_htm.xml XML 3711
Mailing Address 100 SPY COURT MARKHAM A6 L3R 5H6
Business Address 100 SPY COURT MARKHAM A6 L3R 5H6 (905) 475-1234
Edesa Biotech, Inc. (Filer) CIK: 0001540159 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-37619 | Film No.: 24615303
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)